Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11434414 | 0.86 | TBXAS1 (0.34) | TBXAS1TET2 | |
| SCHEMBL13010132 | 0.82 | TSHR (0.34) | POLBGAANPSR1 | |
| SCHEMBL1803764 | 0.79 | POLB (0.39) | POLBGAANPSR1 | |
| SCHEMBL37083 | 0.79 | POLB (0.39) | POLBGAANPSR1 | |
| SCHEMBL8652621 | 0.79 | TBXAS1 (0.31) | TBXAS1 | |
| SCHEMBL8653034 | 0.79 | TET2 (0.35) | TBXAS1TET2 | |
| SCHEMBL30719950 | 0.78 | TET2 (0.39) | TET2 | |
| SCHEMBL28902649 | 0.77 | NAAA (0.40) | POLBGAANPSR1 | |
| SCHEMBL651971 | 0.77 | NAAA (0.40) | POLBGAANPSR1 | |
| SCHEMBL2632255 | 0.77 | HSD17B10 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | claimed |
| EP-3042645-B1 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2022-04-27 | — | — | EP | claimed |
| WO-2016110571-A1 | DENTAL COMPOSITES WITH IMPROVED STORAGE STABILITY | IVOCLAR VIVADENT AG (LI) | 2016-07-14 | — | — | WO | claimed |
| EP-3042645-A1 | Dental composites with improved storage stability | Ivoclar Vivadent AG (LI) | 2016-07-13 | — | — | EP | claimed |
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | disclosed |
| EP-3042645-B1 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2022-04-27 | — | — | EP | disclosed |
| EP-3233934-B1 | REACTION RESIN COMPOSITION AND ITS USE | HILTI AG (LI) | 2021-10-20 | — | — | EP | disclosed |
| EP-3019573-B1 | REACTION RESIN COMPOSITION AND ITS USE | HILTI AG (LI) | 2017-08-23 | — | — | EP | disclosed |
| EP-3184499-A1 | REACTION RESIN COMPOSITION, MULTI-COMPONENT SYSTEM AND ITS USE | HILTI Aktiengesellschaft (LI) | 2017-06-28 | — | — | EP | disclosed |
| WO-2016110571-A1 | DENTAL COMPOSITES WITH IMPROVED STORAGE STABILITY | IVOCLAR VIVADENT AG (LI) | 2016-07-14 | — | — | WO | disclosed |
| EP-3042645-A1 | Dental composites with improved storage stability | Ivoclar Vivadent AG (LI) | 2016-07-13 | — | — | EP | disclosed |
| EP-3034520-A1 | Reaction resin composition and its use | HILTI Aktiengesellschaft (LI) | 2016-06-22 | — | — | EP | disclosed |
| EP-2824155-A1 | Reaction resin composition and its use | HILTI Aktiengesellschaft (LI) | 2015-01-14 | — | — | EP | disclosed |
| US-7863396-B2 | Silicon compounds | CHISSO CORPORATION (JP) | 2011-01-04 | — | — | US | disclosed |
| US-7687593-B2 | Fluorinated polymer and polymer composition | CHISSO CORPORATION (JP) | 2010-03-30 | — | — | US | disclosed |
| US-7375170-B2 | Organosilicon compound | CHISSO CORPORATION (JP) | 2008-05-20 | — | — | US | disclosed |
| US-20070135602-A1 | Fluorinated polymer and polymer composition | CHISSO CORPORATION | 2007-06-14 | — | — | US | disclosed |
| US-20060287454-A1 | Silicon compounds | JNC CORPORATION (JP) | 2006-12-21 | — | — | US | disclosed |
| US-20060175684-A1 | Organosilicon compound | JNC PETROCHEMICAL CORPORATION (JP) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287454-A1 | Silicon compounds | H1-0, SPTBN1, SPTAN1 | TBXAS1 3146/4885TET2 2483/4885POLB 1348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.